WJNS  Vol.5 No.5 , November 2015
Adiponectin Receptor 1 Single Nucleotide Polymorphism Is Highly Associated with Hypertriglyceridemia in Asian Male—A Novel Genetic Screening to Reduce Risk of Cerebrovascular Disease
ABSTRACT
Background: Adiponectin is involved in regulating both glucose and fatty acid. Associations of the known adiponectin receptors 1 (ADIPOR1) single nucleotide polymorphism (SNP) with diabetes have been demonstrated while hypertriglyceridemia is frequently associated with cerebrovascular disease (CVD) among diabetes. Triglyceride metabolism was also reported to be different between genders and estrogen was observed to interfere with adiponectin effects via ADIPOR1. It seems important to investigate whether the ADIPOR1 SNP variants may be significant determinants in triglyceride metabolism and hence be a risk of CVD in specific gender. Methods: A survey was performed on random self-reported healthy subjects aged 35 and above with their biochemical data collected. Genotyping for ADIPOR1 SNP (rs1342387) was carried out using TaqMan Genotyping Assays. Interviews were also conducted regarding stress, adverse diet behavior and exercise. Multivariable logistic regression analyses were performed to identify the strongest contributing variables. Findings: The ADIPOR1 minor allele carrier (T/T and T/C) had significantly (p = 0.02) higher TG mean compared to homozygous (C/C) major alleles. TG difference was significantly higher in male (p = 0.02) with a larger difference in mean, whereas the difference disappeared among female (p = 0.32). Multivariate logistic regression analyses were performed by defining abnormal TG based on NCEP criteria of metabolic syndrome, and when all life variables were entered in the model with ADIPOR1, only the ADIPOR1 inmale showed significant (p = 0.03) and very high association with abnormal TG (Exp(β) 16.31). Discussion: The findings provide sample evidence of a relation between ADIPOR1 SNP minor allele carrier and high TG concentrations in male. The association of abnormal TG and ADIPOR1 is much stronger than that compared to life . The implications of this survey may be further extend to identifying the genetic risk of abnormal TG at young age and reduce the CVD incidence by early intervention.

Cite this paper
Huang, W. , Chen, R. and Yang, Y. (2015) Adiponectin Receptor 1 Single Nucleotide Polymorphism Is Highly Associated with Hypertriglyceridemia in Asian Male—A Novel Genetic Screening to Reduce Risk of Cerebrovascular Disease. World Journal of Neuroscience, 5, 323-327. doi: 10.4236/wjns.2015.55029.
References
[1]   Ginsberg, H.N., Zhang, Y.L. and Hernandez-Ono, A. (2005) Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes [Review]. Archives of Medical Research, 36, 232-240.
http://dx.doi.org/10.1016/j.arcmed.2005.01.005

[2]   Shin, D.W., Lee, K.B., Seo, J.Y., Kim, J.S., Roh, H., Ahn, M.Y., et al. (2015) Association between Hypertriglyceridemia and Lacunar Infarction in Type 2 Diabetes Mellitus. Journal of Stroke and Cerebrovascular Diseases, 24, 1873-1878. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.030

[3]   Mather, K.J., Funahashi, T., Matsuzawa, Y., Edelstein, S., Bray, G.A., Kahn, S.E., et al. (2008) Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program. Diabetes, 57, 980-986. http://dx.doi.org/10.2337/db07-1419

[4]   Mather, K.J., Christophi, C.A., Jablonski, K.A., Knowler, W.C., Goldberg, R.B., Kahn S.E., et al. (2012) Common Variants in Genes Encoding Adiponectin (ADIPOQ) and Its Receptors (ADIPOR1/2), Adiponectin Concentrations, and Diabetes Incidence in the Diabetes Prevention Program. Diabetic Medicine, 29, 1579-1588. http://dx.doi.org/10.1111/j.1464-5491.2012.03662.x

[5]   Olefsky, J., Farquhar, J.W. and Reaven, G.M. (1974) Sex Difference in the Kinetics of Triglyceride Metabolism in Normal and Hypertriglyceridaemic Human Subjects. European Journal of Clinical Investigation, 4, 121-127. http://dx.doi.org/10.1111/j.1365-2362.1974.tb02324.x

[6]   Mauro, L., Pellegrino, M., De Amicis, F., Ricchio, E., Giordano, F., Rizza, P., et al. (2014) Evidences that Estrogen Receptor α Interferes with Adiponectin Effects on Breast Cancer Cell Growth. Cell Cycle, 13, 553-564. http://dx.doi.org/10.4161/cc.27455

[7]   (2011) Taking Sex into Account in Medicine. The Lancet, 378, 1826.

[8]   Crow, J.F. (1999) Hardy, Weinberg and Language impediments. Genetics, 152, 821-825.

[9]   Laloux, P., Galanti, L. and Jamart, J. (2004) Lipids in Ischemic Stroke Subtypes. Acta Neurologica Belgica, 104, 13-19.

[10]   Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., et al. (2007) Triglycerides and the Risk of Coronary Heart Disease: 10,158 Incident Cases among 262,525 Participants in 29 Western Prospective Studies. Circulation, 115, 450-458.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.637793

 
 
Top